[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@RNAiAnalyst Avatar @RNAiAnalyst Dirk Haussecker

Dirk Haussecker posts on X about $srpt, $arwr, $alny, $prme the most. They currently have XXXXXX followers and 1527 posts still getting attention that total XXXXXX engagements in the last XX hours.

Engagements: XXXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence stocks cryptocurrencies finance

Social topic influence $srpt #2, $arwr #1, $alny, $prme, $beam, $rna, $verv, $lly, $ntla, $qure

Top assets mentioned Sarepta Therapeutics, Inc. (SRPT) Arrowhead Research Corporation (ARWR) Alnylam Pharmaceuticals, Inc. (ALNY) BEAM (BEAM) Avidity Biosciences, Inc. Common Stock (RNA) Eli Lilly and Company (LLY) Intellia Therapeutics, Inc (NTLA) Dyne Therapeutics, Inc. Common Stock (DYN) Amgen, Inc. (AMGN) BridgeBio Pharma, Inc. Common Stock (BBIO) Pfizer, Inc. (PFE) Biogen Inc (BIIB) Protagonist Therapeutics, Inc (PTGX) CRISPR Therapeutics AG (CRSP) Novartis AG (NVS) Novo-Nordisk (NVO) Smart Layer Network (SLN) Ionis Pharmaceuticals, Inc. Common Stock (IONS) Novavax Inc (NVAX) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL)

Top Social Posts #

Top posts by engagements in the last XX hours

"$SRPT decides that Elevidys will stay on the market for ambulatory patients. Let's see how insurers react"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-18 23:27:34 UTC 19.6K followers, 6773 engagements

"@scartissue123 MD1 is in the clinic already. Imminent trial results could catapult. Market is big. $rna $dyn $srpt $arwr"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-19 10:09:51 UTC 19.6K followers, XXX engagements

"$SRPT also FDA had known about LGMD fatality a month ago. The only reason to pull Elevidys now would be cause they feel embarrassed by mgmt actions. This would also mean that the journalists that sensationalized the LGMD death would be responsible for denying DMD boys access"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-18 22:44:24 UTC 19.6K followers, 9355 engagements

"Really interesting question where $NTLA-2001 will fall in this step-edit dynamics for ATTR-CM. For genome editing in ATTR-CM the earlier the more cost effective. By that logic $NTLA-2001 used first then $BBIO/Pfizer.nobody would pay for 2nd knockdown agent"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-07 21:40:33 UTC 19.6K followers, 6352 engagements

"$srpt journalists need to think twice before rushing to publish sensational stories after they got a tip from hedge funds. The Friday timing one day following re-org strongly suggests to me that a short gave them the scoop. Hero's work I guess"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-20 21:34:05 UTC 19.6K followers, 9715 engagements

"$srpt Imagine these reporters made a big story out of every CAR-T cell-related death. I would like to remind them that they too are 'gene therapies'. It is more fun though to pick on smaller 'story biotechs' than Big Pharma"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-19 14:39:21 UTC 19.6K followers, 22.6K engagements

"$DYN FDA is right to ask for functional (vHOT) endpoint instead of abstract splicing index for AA in DM1. It's good for everybody really. $PEPG $RNA"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-06-17 12:16:22 UTC 19.6K followers, 2927 engagements

"$VERV $X CVR for starting p3 ASCVD trial currently priced at $XXXX almost as if $LLY=Big Pharma only acquired VERVE-102 to retire yet another 'gene therapy' so it won't compete with conventional drugs. $PFE $SGMO"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-14 08:43:34 UTC 19.6K followers, 5174 engagements

"I like that. While $beam has prime views of Boston and Charles River from the terraces of their glass palace $prme employees get to see their benches during lunch :)"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-17 18:21:28 UTC 19.6K followers, 2767 engagements

"#biotech so a new strategy is to manipulate the new US admin into taking action assuming they only care a out appearances Seems to be working out so far"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-19 13:36:35 UTC 19.5K followers, 2475 engagements

"Small dosing adjustments to #Alzheimer's antibody reduced ARIA adverse event from XX% -- XX% at week XX from 25%-- XX% at week XX. .while plaque removal remains 'similar'. $LLY $BIIB"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-09 11:52:12 UTC 19.6K followers, 2950 engagements

"$ptgx -X% on presenting data on selected drug candidate a year before being clinical. Guess that teaches other biotechs not to prominently talk abt early pipeline"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-01 22:49:20 UTC 19.6K followers, 4623 engagements

"After $VERV and $PRME (and somewhat $EDIT).which $CRISPR stock is about to fire up the turbo next"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-07 16:18:08 UTC 19.5K followers, 4060 engagements

"@MartinShkreli The SMA gene therapy sh*tstorm lasted about X days and #Novartis wasnt really transparent either. Big Pharma vs Story Biotech. $srpt"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-20 08:31:44 UTC 19.6K followers, 1045 engagements

"Would not rule out disgruntled laid-off employees either. At today's @endpts post-hoc it was all about enticing $srpt (ex) employees of violating their agreements to spill the beans. Endpoints said they got contacted on Thu abt why patient death not disclosed"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-21 19:49:29 UTC 19.6K followers, 2412 engagements

"Trump just now: #Powell is a 'numbskull' not lowering rates for political reasons (last time was before elections); people can't afford to build homes. One of the few items I agree with Trump on. #biotech"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-22 16:27:48 UTC 19.6K followers, 1792 engagements

"$srpt Which regulator would use the terms #treacherous and #arduous path when it comes to getting a drug safely back onto the market Sounds biased from the get-go and hints that there's a leak within #FDA with trading interest"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-23 05:57:40 UTC 19.6K followers, XXX engagements

"#BREAKING Trump just said rates 'should be X points lower'. Imagine what that would mean for #biotech"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-22 16:29:35 UTC 19.6K followers, 2486 engagements

"The $SRPT subQ SRP-1005 for #Huntington's does NOT target exon X transcript. Very unfortunate. When I did my Huntington's deep dive I came away w/ that this is a MUST. It can be done see $QURE and $ALNY. Stop wasting time develop exon X subQ. h/t @JamesMclaw70633"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-17 21:35:13 UTC 19.6K followers, 6128 engagements

"@BioStocks hey @grok which investment banks/analyst shops have the worst reputation in biotech"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-21 12:42:17 UTC 19.6K followers, 1684 engagements

"#portfolio been a nice XXX% run over last X months. My $SRPT accident* a timely reminder that none of us #biotech traders are immortal.unless you trade on inside information. *buying on re-org news only to be hit by LGMD news next day"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-18 12:29:25 UTC 19.5K followers, 4404 engagements

"Loaded up on $ARWR. Possible $SRPT sold some. Crazy sell-off on $srpt news from $XX to $14.3"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-22 14:39:56 UTC 19.6K followers, 7336 engagements

"$SRPT impressive results for SUBQ delivery to CNS. Is this huntington's candidate targeting exon X $QURE $ALNY"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-16 21:06:04 UTC 19.6K followers, 19.4K engagements

"$LLY $NVO notable that the X leading #obesity/Glp1 players have heavily invested in #RNAi esp for metabolic disease (via $DRNA partnership/acquisition). $ARWR $SLN"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2023-08-17 09:45:49 UTC 19.6K followers, 4412 engagements

"Curiously $SRPT/Arrowhead DM1 program is peptide-targeted to alphavbeta6 integrin. Was TfR1 also in the running for DM1 $RNA"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-21 16:50:02 UTC 19.6K followers, 2577 engagements

"$ALNY treading water in this biotech bull tape as they watch valuation of $PRME quadruple in short order. What a generational missed opportunity to fortify their franchises. Still there is $NTLA for them but I'm just a tweeter on X"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-09 14:55:19 UTC 19.6K followers, 3681 engagements

"$srpt a 'journalist' writing about drug development calls an analyst a 'hero' for downgrading the stock.yes not families struggling w/ what to do now but an analyst helping the shorts"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-20 18:56:57 UTC 19.6K followers, 19.6K engagements

"$capr if Vinay Prasad were still on X and tweet about biotech stocks he'd present a thesis on why to be short ahead of p3 readout. The CRL is his way of saying he does not believe in it but willing to give Co a chance"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-11 18:28:30 UTC 19.6K followers, 2976 engagements

"$verv tomorrow is the end of the tender offer period for the acquisition that gave the #CRISPR industry a new life"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-22 18:02:17 UTC 19.6K followers, 2043 engagements

"$lly RNAi drug. 2029 primary completion. $nvs $ions and $amgn $arwr next year read-out. Lpa"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-11 09:44:26 UTC 19.6K followers, 6410 engagements

"$SRPT hedge funds were behind it journalists the tool: 1) on Wed July XX Co announces re-org stock up XX% 2) instead of sustaining rise (guided p/e floor of 4) stock keeps selling off on Thu. 3) journalists getting informed Thu night 4) publications sow panic 5) FDA acts"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-21 06:56:30 UTC 19.6K followers, 9380 engagements

"$srpt sure DI is a goner but to take on this job A smooth well-connected operator who gets lots of options similar to $nvax It definitely cannot be somebody from inside the company. Ian step a son and claypot have been complicit in the lies too"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-19 19:10:55 UTC 19.6K followers, 2855 engagements

"I won't tire saying it but with $ALNY MC42x $NTLA MC and $NTLA-2001 not yet commercial (antitrust) they still have an opportunity to go after $NTLA"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-07 21:42:55 UTC 19.6K followers, 2453 engagements

"@nociFTW not the journalists the hedge funds (perhaps via FDA leaks)"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-21 06:57:05 UTC 19.6K followers, XXX engagements

"$PRME Great to meet the new CEO. The Great: financially deliberate broad biotech experience The Bad: dilution coming ('lots of investor interest') no word on PRV opportunity for CGD (or $BEAM FTO). Partner would not be a normal pharma. Not sure where this leaves the PRV"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-17 20:29:13 UTC 19.6K followers, 4647 engagements

"$SRPT obvious insider trading*. Took it down to $XX which should be the minimum floor today. *is it insider trading if through deep research you find out about a patient death and trade on it"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-18 13:23:10 UTC 19.6K followers, 11.6K engagements

"HYPE XXX crypto -- +300% in pre-market. Drug development is hard fleecing people with crypto.easy. $SONN"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-14 10:32:31 UTC 19.6K followers, 8817 engagements

"@jfais20 SHTG critical but yeah momentum building also AATD (50% US) and Lpa next year. $arwr $amgn"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-21 14:29:19 UTC 19.6K followers, 1311 engagements

"$CAPR CRL'd. There is still HOPE (-3) in Q3 '25. Unusually candid discussion of CRL content (since it might become public anyway)"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-11 11:39:51 UTC 19.5K followers, 3212 engagements

"$MDGL $500M loan to finance MASH pipeline extension. Guess they'll go for an oligo modality like #RNAi #RNAediting maybe #CRISPR"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-22 18:18:00 UTC 19.6K followers, 2940 engagements

"$srpt to my knowledge Roche has not stopped shipping elevidys for ambulant population nor have other health agencies come out demanding further restrictions following last week's disclosure of LGMD death. Let that sink in"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-22 11:16:03 UTC 19.6K followers, 6103 engagements

"Analysts on the $SRPT call right now: please ask this question. If it targets exon X it could be a tremendously valuable program esp if upcoming $QURE 3-year data positive. Would likely leap-frog $ALNY's program too. $ARWR"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-16 21:18:42 UTC 19.6K followers, 10.8K engagements

"$arwr what surprised me from the $SRPT huntington's program disclosure is that subQ CNS delivery involves an antibody fragment targeting TfR1.the same target used in $RNA's bivalent mAb-targeted DM1 program"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-21 16:45:37 UTC 19.6K followers, 6406 engagements

"@wkissel @BowTiedBiotech @aasgardinvest I believe for non-immunostimulatory #RNAi agents in #HBV time to shift focus from 'functional cure' to outcomes study following chronic semiannual treatment. $ARWR"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-07 11:10:26 UTC 19.6K followers, XXX engagements

"$SRPT based on Feuerstein on @BiotechCH at least X journalist groups had known of LGMD death. U bet a few hedge funds knew too. Must have been fun for them watch retail 1st being confused about sell-off month ago then buying on re-org. Co enabled them by not disclosing"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-18 22:38:31 UTC 19.6K followers, 8428 engagements

"#CRISPR when @davidrliu had to choose btw prime vs base editing for point mutations: X of X mutations amenable to base editing. .but X of these X unacceptable bystander editing -- chose BE for X prime editing for the rest (4) $PRME $BEAM"
@RNAiAnalyst Avatar @RNAiAnalyst on X 2025-07-22 06:27:57 UTC 19.6K followers, 2748 engagements